Earnings Feed
Start Free
Home/Filings/4/0001104659-10-052110
4//SEC Filing

ZYMOGENETICS INC 4

Accession 0001104659-10-052110

CIK 0001129425operating
View on SEC.govCompany Profile

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 7:58 PM ET

Size

30.9 KB

Accession

0001104659-10-052110

Insider Transaction Report

Form 4
Period: 2010-10-07
ZYMOGENETICS INCZGEN
LEFF JONATHAN S
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to buy)

    2010-10-12−6,803→ 0 total
    Exercise: $14.70Exp: 2013-06-12→ Common Stock (0 underlying)
  • Disposition to Issuer

    Stock Option (Right to buy)

    2010-10-12−7,500→ 0 total
    Exercise: $18.50Exp: 2016-06-15→ Common Stock (0 underlying)
  • Disposition to Issuer

    Stock Option (Right to buy)

    2010-10-12$2.26/sh−13,352$30,176→ 0 total
    Exercise: $7.49Exp: 2012-06-21→ Common Stock (13,352 underlying)
  • Disposition from Tender

    Common Stock, no par value per share

    2010-10-07$9.75/sh−9,387,559$91,528,700→ 0 total(indirect: See footnotes)
  • Disposition to Issuer

    Stock Option (Right to buy)

    2010-10-12$5.15/sh−12,000$61,800→ 0 total
    Exercise: $4.60From: 2011-06-17Exp: 2020-06-17→ Common Stock (12,000 underlying)
Footnotes (6)
  • [F1]See Note 1 on Exhibit 99.1 attached hereto.
  • [F2]See Note 2 on Exhibit 99.1 attached hereto.
  • [F3]This unvested option was cancelled pursuant to the terms of the Agreement and Plan of Merger between ZymoGenetics, Inc. (the "Company"), Bristol-Myers Squibb Company and Zeus Acquisition Company, dated September 7, 2010 (the "Merger Agreement") in exchange for a cash payment representing the number of shares of the Company's Common Stock underlying such option multiplied by the difference between the exercise price of the option and the per share purchase price of $9.75.
  • [F4]This option is fully vested.
  • [F5]This option was canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment representing the number of shares of the Company's Common Stock underlying such option multiplied by the difference between the exercise price of the option and the per share purchase price of $9.75.
  • [F6]This option was canceled pursuant to the terms of the Merger Agreement without cash payment, as the exercise price of the option is greater than the per share purchase price of $9.75.

Documents

2 files

Issuer

ZYMOGENETICS INC

CIK 0001129425

→
Entity typeoperating
IncorporatedWA

Related Parties

1
  • filerCIK 0001129425

Filing Metadata

Form type
4
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 7:58 PM ET
Size
30.9 KB
View on SEC.gov